N

NovoCure Limited

D
NVCR
USD
0.23
(1.3061%)
Market Closed
27,797.00
Volume
-1.32
EPS
-
Div Yield
-11.291139
P/E
1,930,600,021.60
Market Cap
Today
1.3061%
1 Week
2.884%
1 Month
-1.436%
6 Months
31.661%
12 Months
-1.816%
Year To Date
19.411%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ISRG
ISRG
7.7
(1.5972%)
USD
I
ICUI
5.02
(2.8502%)
USD
M
MMSI
1.45
(1.4689%)
USD
A
ARAY
-0.015
(-0.7874%)
USD
T
TNDM
1.77
(4.1501%)
USD
V
VCYT
1.51
(4.4727%)
USD
G
GH
0.3
(1.1952%)
USD
T
TMDI
-0.0123
(-5.9564%)
USD
O
OMI
0.22
(1.3915%)
USD
B
BAX
-0.615
(-1.5619%)
USD

Title:
NovoCure Limited

Sector:
Healthcare
Industry:
Medical Devices
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatmentof solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derivesmajority of its revenue from the United States and rest from Germany, Japan and other markets.
Do you need help or have a question?
Contact Us